APA

Portelius E., Dean R. A., Andreasson U., Mattsson N., Westerlund A., Olsson M., Demattos R. B., Racke M. M., Zetterberg H., May P. C. & Blennow K. (20141118). β-site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage. : Alzheimer's research & therapy.

Chicago

Portelius Erik, Dean Robert A, Andreasson Ulf, Mattsson Niklas, Westerlund Anni, Olsson Maria, Demattos Ronald Bradley, Racke Margaret M, Zetterberg Henrik, May Patrick C and Blennow Kaj. 20141118. β-site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage. : Alzheimer's research & therapy.

Harvard

Portelius E., Dean R. A., Andreasson U., Mattsson N., Westerlund A., Olsson M., Demattos R. B., Racke M. M., Zetterberg H., May P. C. and Blennow K. (20141118). β-site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage. : Alzheimer's research & therapy.

MLA

Portelius Erik, Dean Robert A, Andreasson Ulf, Mattsson Niklas, Westerlund Anni, Olsson Maria, Demattos Ronald Bradley, Racke Margaret M, Zetterberg Henrik, May Patrick C and Blennow Kaj. β-site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage. : Alzheimer's research & therapy. 20141118.